ID
22686
Beskrivning
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Nyckelord
Versioner (2)
- 2017-06-09 2017-06-09 -
- 2017-06-09 2017-06-09 -
Rättsinnehavare
Genentech, Inc.
Uppladdad den
9 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382
Similar models
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382
C0229089 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0229090 (UMLS CUI [2,2])
C0032042 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0042164 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0234632 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0578862 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C2880797 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0038901 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])